Kura Oncology Quote - KURA

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

8.5875

Bid

8.58

Offer

8.59

Volume

746,139

8.50 Day's Range 8.71

8.42 52 Week Range 24.17

Market Cap

667.796M

Previous Close

8.51

Open

8.57

Last Trade

249

8.5844

(average)

Last Trade Time

07:32:49

Financial Volume

US$ 6,390,045

VWAP

8.5641

Average Volume (3m)

1,771,590

Shares Outstanding

77,763,750

Dividend Yield

PE Ratio

-4.35

Earnings Per Share (EPS)

-1.96

Revenue

Net Profit

-152.63M

Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signalling pathways to drive the progressi... Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signalling pathways to drive the progression of various cancers. The company has a lead product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. It is advancing KO-947, a small molecule inhibitor of extracellular-signal-regulated kinase (ERK), as a treatment for patients with pancreatic cancer, colorectal cancer, non-small cell lung cancer (NSCLC) and melanoma. Geographically operation of the group is carried through the United States. Show more

Sector

Pharmaceutical Preparations

Industry

Blank Checks

Website

www.kuraoncology.com

Headquarters

Wilmington, Delaware, USA

Founded

2015

Kura Oncology Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker KURA. The last closing price for Kura Oncology was US$8.51. Over the last year, Kura Oncology shares have traded in a share price range of US$ 8.42 to US$ 24.17.

Kura Oncology currently has 77,763,750 shares in issue. The market capitalisation of Kura Oncology is US$661.77 million. Kura Oncology has a price to earnings ratio (PE ratio) of -4.35.

Form 8-K - Current report

Kura Oncology and Kyowa Kirin Report Positive Combination Data for Ziftomenib at American Society of Hematology Annual Meeting

– Interim analysis from Phase 1a portion of KOMET-007 shows 100% CR rate in NPM1-m and 83% CR rate in KMT2A-r 1L adverse risk AML with 7+3 – – 100% of 1L NPM1-m and 96% of 1L KMT2A-r AML patients...

Kura Oncology to Host Virtual Investor Event on December 9, 2024

SAN DIEGO, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the...

Kura Oncology to Participate in JMP Securities Hematology and Oncology Summit

SAN DIEGO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the...

Form 8-K - Current report

Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias

Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias PR Newswire SAN DIEGO and TOKYO, Nov. 20, 2024 – Kura to receive a...

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.3225	-3.61952861953	8.91	9.07	8.42	1266186	8.69820147	CS
4	-2.5225	-22.704770477	11.11	11.39	8.42	1800730	9.59173359	CS
12	-9.4025	-52.2651473041	17.99	19.7283	8.42	1771590	11.78815214	CS
26	-11.9225	-58.1301803998	20.51	23.48	8.42	1129256	14.09035974	CS
52	-5.8825	-40.6530753283	14.47	24.17	8.42	1112393	16.89623903	CS
156	-5.8825	-40.6530753283	14.47	24.17	7.41	917512	14.52962127	CS
260	-5.3925	-38.5729613734	13.98	42.82	6.34	805250	17.25948358	CS

KURA - Frequently Asked Questions (FAQ)

What is the current Kura Oncology share price?

The current share price of Kura Oncology is US$ 8.5875

How many Kura Oncology shares are in issue?

Kura Oncology has 77,763,750 shares in issue

What is the market cap of Kura Oncology?

The market capitalisation of Kura Oncology is USD 661.77M

What is the 1 year trading range for Kura Oncology share price?

Kura Oncology has traded in the range of US$ 8.42 to US$ 24.17 during the past year

What is the PE ratio of Kura Oncology?

The price to earnings ratio of Kura Oncology is -4.35

What is the reporting currency for Kura Oncology?

Kura Oncology reports financial results in USD

What is the latest annual profit for Kura Oncology?

The latest annual profit of Kura Oncology is USD -152.63M

What is the registered address of Kura Oncology?

The registered address for Kura Oncology is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801

What is the Kura Oncology website address?

The website address for Kura Oncology is www.kuraoncology.com

Which industry sector does Kura Oncology operate in?

Kura Oncology operates in the BLANK CHECKS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BDMDBaird Medical Investment Holdings Ltd	US$ 8.39 (699.05%)	81.26M
APMAptorum Group Ltd	US$ 3.67 (170.85%)	112.28M
ONCOOnconetix Inc	US$ 1.125 (157.44%)	258.04M
VRMEVerifyMe Inc	US$ 1.3711 (73.58%)	92.24M
COEPCoeptis Therapeutics Holdings Inc	US$ 4.81 (55.16%)	2.13M
SGMOSangamo Therapeutics Inc	US$ 0.9425 (-59.72%)	38.39M
WATTEnergous Corporation	US$ 1.115 (-57.92%)	26.63M
INTZIntrusion Inc	US$ 3.0999 (-45.42%)	14.03M
KZIAKazia Therapeutics Ltd	US$ 1.79 (-42.26%)	630.48k
COCPCocrystal Pharma Inc	US$ 2.0552 (-36.76%)	481.5k
SVMHSRIVARU Holding Ltd	US$ 0.045 (34.73%)	777.87M
XTIAXTI Aerospace Inc	US$ 0.042 (6.33%)	425.47M
EYENEyenovia Inc	US$ 0.1472 (29.92%)	398.98M
CRKNCrown Electrokinetics Corporation	US$ 0.1399 (0.87%)	381.62M
ONCOOnconetix Inc	US$ 1.14 (160.87%)	258.06M